Virology & Mycology
Open Access

Improved molecular surveillance and new therapeutic responses to the influenza virus using mass spectrometry

2^nd International Conference on Flu

October 31-November 02, 2016 San Francisco, USA

Kevin Downard

University of New South Wales, Australia

Posters & Accepted Abstracts: Virol Mycol

Abstract :

The influenza virus is one of the deadliest pathogens known to man, responsible for the death of the equivalent of 1 in 1000 humans who have ever lived. Seasonal influenza accounts for about 3 to 5 million cases of severe illness requiring hospitalization and 250,000 to 500,000 deaths worldwide each year. A worldwide surveillance network, overseen by the WHO, assesses circulating strains and makes recommendations for the annual vaccine formulation ahead of the flu season in both the northern and southern hemisphere. Yet unforeseen evolutionary events and growing resistance to current antiviral inhibitors can lead the population unprotected. Furthermore, limitations in current screening technologies can delay and negatively impact on the implementation of effective infection controls. New molecular based surveillance technologies employing advanced mass spectrometry and bioinformatic approaches offer advantages for the characterization of circulating strains, the study of viral evolution and the identification and development of new antiviral inhibitors, including those based on natural products. This presentation will review these approaches that have attracted interest from global surveillance laboratories and have broader application to the study of other biopathogens which threaten human health.

Biography :

Email: k.downard@unsw.edu.au